Role of ROS and autophagy in the pathological process of atherosclerosis
Journal of Physiology and Biochemistry · 2024
DOI: 10.1007/s13105-024-01039-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Physiology and Biochemistry, 2024. Verfasst von Liyuan Zhu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Atherosclerosis, Autophagy. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 131 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Activation of autophagy and production of reactive oxygen species occur at various stages of atherosclerosis. To clarify the role and mechanism of autophagy and reactive oxygen species in atherosclerosis is of great significance to the prevention and treatment of atherosclerosis. Recent studies have shown that basal autophagy plays an important role in protecting cells from oxidative stress, reducing apoptosis and enhancing atherosclerotic plaque stability. Autophagy deficiency and excessive accumulation of reactive oxygen species can impair the function of endothelial cells, macrophages and smooth muscle cells, trigger autophagic cell death, and lead to instability and even rupture of plaques. However, the main signaling pathways regulating autophagy, the molecular mechanisms of autophagy and reactive oxygen species interaction, how they are initiated and distributed in plaques, and how they affect atherosclerosis progression, remain to be clarified. At present, there is no autophagy inducer used to treat atherosclerosis clinically. Therefore, it is urgent to clarify the mechanism of autophagy and find new targets for autophagy. Antioxidant agents generally have defects such as low reactive oxygen species scavenging efficiency and high cytotoxicity. Highly potent autophagy inducers and reactive oxygen species scavengers still need to be further developed and validated to provide more possibilities for innovative treatments for atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Department of Laboratory Medicine, Sichuan Provincial Key Laboratory for Human Disease Gene Study and the Center for Medical Genetics, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Univer…
- Research Unit for Blindness Prevention, Chinese Academy of Medical Sciences (2019RU026), Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.
- Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. jiangbo@zju.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, L., Liao, Y., & Jiang, B. (2024). Role of ROS and autophagy in the pathological process of atherosclerosis. Journal of Physiology and Biochemistry. https://doi.org/10.1007/s13105-024-01039-6
Vancouver
Zhu L, Liao Y, Jiang B. Role of ROS and autophagy in the pathological process of atherosclerosis. Journal of Physiology and Biochemistry. 2024. doi:10.1007/s13105-024-01039-6
BibTeX
@article{Zhu2024,
author = {Zhu, Liyuan and Liao, Yingnan and Jiang, Bo},
title = {Role of ROS and autophagy in the pathological process of atherosclerosis},
journal = {Journal of Physiology and Biochemistry},
year = {2024},
doi = {10.1007/s13105-024-01039-6}
}
EUVIMED